Perrigo to sell generic drugs business for $1.55 billion

Perrigo to sell generic drugs business for $1.55 billion

Perrigo Company on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business. The sale, to private equity firm...
Kingswood SPAC and Apollo among suitors for Blackstone’s Lombard

Kingswood SPAC and Apollo among suitors for Blackstone’s Lombard

A so-called ‘blank cheque’ company set up by a group of financiers is weighing a merger with Lombard International, one of the largest UK-based wealth management groups. Sky News has learnt that Kingswood Acquisition Corp, which listed in New York late last year, is...